Promethos Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Promethos Capital's NVS Position: Q3 2026 in Review
Promethos Capital sold out of Novartis (NVS) in Q3 2026, closing a stake of 233,303 shares — an estimated $36.6M sold.
Promethos Capital first reported a position in NVS in Q1 2024 and held it in 10 quarters. The position peaked at $36.6M in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Promethos Capital reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- Promethos Capital sold 233,303 Novartis shares in Q3 2026, an estimated $36.6M.
- Promethos Capital first reported a position in Novartis in Q1 2024 and held it in 10 quarters.
- Promethos Capital's Novartis position peaked at $36.6M in Q2 2026.
- 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Promethos Capital's 13F filing for Q3 2026, filed 13 Nov 2026.